656
B. Binotti et al. / Journal of Organometallic Chemistry 689 (2004) 647–661
AgCl precipitated, the mixture was filtered through
Celite. A red oil was obtained after evaporation of the
solvent under vacuum. The product, upon treatment
with cold hexane (3 ꢅ 5 ml), gave compound 1 as an
orange powder (550 mg, 0.78 mmol, yield: 87%). Crystal
suitable for an X-ray structure determination were ob-
tained by slow diffusion of hexane into a dichlorome-
thane solution of 1 at )30 °C. IR (Nujol, cmꢀ1): 1626.4
C14 and C16), 129.4, 125.9, 125.1 (s, C26, C27 and C28),
111.7 (s, C1), 107.0 (s, C2), 80.7 (s, C5), 57.9 (s, C6), 56.1
(s, C9), 33.7 (s, C7), 31.6 (s, C4), 29.7 (s, C33), 28.9 (s,
C30 and C3), 25.9 (s, C8), 25.0 (s, C34), 24.6 (s, C31),
24.3 (s, C18), 24.2 (s, C32), 23.7 (s, C35). 19F NMR
(CD2Cl2, 217 K) d )151.56 (10BF4), )151.62 (11BF4).
Anal. Calc. for C30H40BF4NO2Pd: C, 56.31; H, 6.30; N,
2.19. Found: C, 56.48; H, 6.42; N, 2.07%.
1
(C@O). H NMR (CD2Cl2, 217 K, J values in Hz): d
3
4
7.76 (tt, JHH ¼ 7:4, JHH ¼ 1:1, H15), 7.61 (brd, H13
4.6. Preparation and characterization of 3
and H17), 7.48 (tt, 3JHH ¼ 7:6, 4JHH ¼ 1:1, H21), 7.46 (t,
3
3JHH ¼ 7:9, H14 and H16), 7.40 (dd, JHH ¼ 7:7,
Complex 3 was synthesized according to the proce-
dure described for 1
using 315 mg of [Pd(g1,
3
4JHH ¼ 1:5, H26), 7.36 (t, JHH ¼ 7:7, H27), 7.27 (t,
3
3JHH ¼ 7:7, H20 and H22), 7.18 (dd, JHH ¼ 7:7,
g2-C8H12OMe)Cl]2 (0.56 mmol), 205 mg of the 2-ben-
zoylpyridine ligand (1.12 mmol) and 230 mg of AgBF4
(1.18 mmol). A 516 mg (1.00 mmol, yield: 90%) sample
of 3 was collected as an yellow powder. IR (Nujol,
cmꢀ1): 1618.1 (C@O). 1H NMR (CD2Cl2, 217 K, J
values in Hz): d 8.84 (br, H21), 8.47 (br, H19), 8.30 (br,
H18), 8.18 (br, H20), 7.84 (m, H13, H17 and H15), 7.67
4JHH ¼ 1:5, H28), 6.95 (brd, H19 and H23), 6.50 (m,
3
H1), 6.16 (m, H2), 3.25 (sept, JHH ¼ 6:6, H33), 3.07
(brd, H5), 2.85 (brd, H3), 2.63 (m, H30), 2.52 (sept,
3JHH ¼ 6:6, H30), 2.42 (m, H6), 2.37 (s, H9), 2.35 (m,
H8 and H80), 2.20 (m, H7), 2.00 (m, H4), 1.89 (m,
3
H40),1.41 (d, JHH ¼ 6:6, H35), 1.32 (m, H70), 1.26 (d,
3
3
3JHH ¼ 6:6, H31), 1.22 (d, JHH ¼ 6:6, H34), 0.20 (d,
(t, JHH ¼ 7:5, H14 and H16), 6.34 (br, H1), 6.04 (br,
3JHH ¼ 6:6, H32). 13C{1H} NMR (CD2Cl2, 217 K): d
199.8 (s, C10), 174.4 (s, C11), 140.0, 139.9, 136.0, 134.5,
130.9 (s, aromatic quaternary carbons), 137.9 (s, C15),
134.2 (s, C21), 132.3 (s, C13 and C17), 129.8 (s, C14 and
C16), 129.7 (s, C27), 129.6 (s, C28), 125.1 (s, C26), 112.9
(s, C1), 106.3 (s, C2), 80.9 (s, C5), 60.8 (s, C6), 56.3 (s,
C9), 34.4 (s, C7), 31.2 (s, C4), 30.4 (s, C33), 28.8 (s, C3),
28.5 (s, C30), 26.0 (s, C8), 25.4 (s, C31), 24.6 (s, C34),
23.4 (s, C35), 22.4 (s, C32). 19F NMR (CD2Cl2, 217 K):
d )152.65 (10BF4), )152.70 (11BF4). Anal. Calc. for
C35H42BF4NO2Pd: C, 59.89; H, 6.03; N, 2.00. Found:
C, 59.91; H, 6.21; N, 1.95%.
H2), 3.72 (brt, H5), 3.37 (s, H9), 3.30 (br, H6), 2.75 (m,
H3 and H30), 2.39 (m, H8, H80 and H7), 2.12 (H4 and
H40), 1.58 (H70). 13C{1H} NMR (CD2Cl2, 217 K): d
201.0 (s, C10), 151.6 (s, C11), 150.9 (s, C21), 150.8 (s,
C12), 142.5 (s, C19), 136.1 (s, C15), 133.4 (s, C18), 132.6
(s, C20), 131.3 (s, C13 and C17), 129.9 (s, C14 and C16),
109.1 (s, C1), 106.4 (s, C2), 81.8 (s, C5), 57.3 (s, C9), 56.9
(s, C6), 34.6 (s, C7), 30.8 (s, C4), 28.7 (s, C3), 26.1 (s,
C8). 19F NMR (CD2Cl2, 217 K): d )152.38 (10BF4),
)152.43 (11BF4). Anal. Calc. for C21H24BF4NO2Pd: C,
48.91; H, 4.69; N, 2.72. Found: C, 49.03; H, 4.74; N,
2.74%.
4.5. Preparation and characterization of 2
4.7. Preparation and characterization of 1a
Complex 2 was synthesized according to the proce-
dure described for
Complex 1a was obtained according to the following
procedures:
1
using 155 mg of [Pd(g1,
g2- C8H12OMe)Cl]2 (0.28 mmol), 172 mg of the 2,6-
(i-Pr)2(C6H3)N@C(Me)–C(Ph)@O ligand (0.56 mmol)
and 115 mg of AgBF4 (0.59 mmol). A 320 mg (0.50
mmol, yield: 90%) sample of 2 was collected as an or-
ange powder. IR (Nujol, cmꢀ1): 1629.8 (C@O). 1H
NMR (CD2Cl2, 217 K, J values in Hz): d 7.97 (d,
A: Complex 1 (88 mg, 0.13 mmol) was dissolved in
dichloromethane (1.5 ml) at )50 °C. To the resulting red
solution, phenylacetylene (13.8 ll, 0.13 mmol) was ad-
ded. The reaction mixture was stirred at )50 °C for 10
min and warmed to )30 °C. After 72 h at this temper-
ature, the red-brown solution was evaporated in a vac-
uum obtaining a brownish oil which, upon treatment
with cold hexane (3 ꢅ 5 ml), gave a brown powder.
Recrystallization with dichloromethane/hexane gave
compound 1a as an orange powder (63 mg, 0.09 mmol,
yield: 70%). Crystal suitable for an X-ray structure de-
termination were obtained by slow diffusion of hexane
into a dichloromethane solution of 1a at )30 °C. IR
3
3JHH ¼ 7:5, H13 and H17), 7.85 (t, JHH ¼ 7:5, H15),
3
7.68 (d, JHH ¼ 7:5, H14 and H16), 7.39 (m, H26, H27
and H28), 6.40 (m, H1), 6.08 (m, H2), 3.09 (m, H5), 3.04
3
3
(sept, JHH ¼ 6:7, H33), 2.91 (sept, JHH ¼ 6:7, H30),
2.80 (brd, H3), 2.61 (m, H30), 2.49 (s, H18), 2.43 (m,
H6), 2.39 (s, H9), 2.30 (m, H8 and H80), 2.19 (m, H7),
1.99 (m, H4), 1.87 (m, H40), 1.40 (d, JHH ¼ 6:7, H31),
3
1.35 (d, JHH ¼ 6:7, H35), 1.26 (m, H70), 1.20 (d,
(Nujol, cmꢀ1): 1626.1 (C@O). H NMR (CD2Cl2, 217
3
1
3JHH ¼ 6:7, H34), 1.17 (d, JHH ¼ 6:7, H32). 13C{1H}
K, J values in Hz): d 7.74 (t, JHH ¼ 7:5, H15), 7.59
3
3
NMR (CD2Cl2, 217 K): d 198.9 (s, C10), 178.2 (s, C11),
139.8, 139.1, 137.6, 134.4 (s, aromatic quaternary car-
bons), 136.9 (s, C15), 131.1 (s, C13 and C17), 129.9 (s,
(brd, H13 and H17), 7.45 (t, 3JHH ¼ 7:5, H14 and H16),
3
7.44 (t, JHH ¼ 7:9, H21 burried under H14 and H16),
3
3
7.39 (t, JHH ¼ 7:7, H27), 7.32 (d, JHH ¼ 7:7, H26),